Changing the Culture of the FDA Act

2/16/2024, 9:08 PM

Congressional Summary of S 604

Changing the Culture of the FDA Act

This bill requires the Food and Drug Administration to amend its mission statement to state that it is responsible for protecting the public health by considering the danger of addiction and overdose death when approving and regulating prescription opioid medications. (Opioid medications are drugs with effects similar to opium, such as certain pain medications.)

Current Status of Bill S 604

Bill S 604 is currently in the status of Bill Introduced since March 1, 2023. Bill S 604 was introduced during Congress 118 and was introduced to the Senate on March 1, 2023.  Bill S 604's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of March 1, 2023

Bipartisan Support of Bill S 604

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
1
Democrat Cosponsors
0
Republican Cosponsors
1
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill S 604

Primary Policy Focus

Health

Alternate Title(s) of Bill S 604

Changing the Culture of the FDA ActChanging the Culture of the FDA ActA bill to direct the Secretary of Health and Human Services to amend the mission statement of the Food and Drug Administration.
Start holding our government accountable!

Comments